Introduction: Deltonin, an active component extracted from Dioscorea zingiberensis C.H. WRIGHT, was widely utilized in traditional Chinese medicines. It has been shown to have anticancer functions such as colon cancer, breast cancer, and head and neck squamous carcinoma. Herein, we will investigate the role of deltonin in cerebral ischemia/reperfusion injuries. Methods: Ly294002 and anisomycin were used as inhibitors to monitor the effects of deltonin. Middle cerebral artery occlusion I/R model was constructed. Infarct volumes, neurological deficits and brain water contents were evaluated under different conditions. Rotarod test, ELISA, and Western blotting were carried to investigate the effects in vitro. Results: We found that deltonin in ischemia/reperfusion (I/R) rats greatly enhanced brain damages as well as neurological functions through up-regulating p-Akt and p-mTOR as well as inhibiting the expressions of LC3-II/LC3-I, Beclin-1, IL-1, TLR4, and p-p38. Deltonin exerted neuroprotection effect through relieving autophagy activity by regulating PI3K/Akt/ mTOR signaling. Deltonin suppressed inflammation reactions through modulation TLR4/ p38/MAPK signaling as well. Conclusion: Overall, our data suggested that deltonin could suppress ischemic brain injury by regulating autophagy and inflammation during I/R. Deltonin can be a potential therapeutic method for patient with I/R.
hypoxia-ischemia. 5, 7 Neuroinflammation caused by ischemia/reperfusion injuries brings damages to the neuron cells. Therefore, the inhibitions of autophagy and inflammation are critical to prevent the neuro-degenerative damages after focal cerebra I/R. 8 PI3K/Akt/mTOR pathway has been proved to play central roles in ischemia-reperfusion (I/R) injuries. For instance, Zhang reported that sevoflurane post-conditioning protected rat hearts against ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signaling. 9 Chen also reported the neuroprotective effects of brainderived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway. 10 In addition, TLR4/p38/MAPK pathway was also reported to be involved in the neuro inflammations in microglia. In 2016, Swaroop reported that HSP60 could regulate IL-1β-related microglial inflammatory reactions through TLR4-p38/MAPK. In this paper, we aim to reveal the functional mechanisms of deltonin, PI3K/Akt/mTOR pathway TLR4-p38 MAPK pathway in the autophagy and inflammation caused by cerebral ischemia/reperfusion injury, as well as their inner associations.
Methods and Materials Reagents
Deltonin with a purity of over 98% was generated as previously described and its purity determined by high-performance liquid chromatography (>98%) according to Tong et al. 1 Figure 1A shows the chemical structure of deltonin.
LY294002, anisomycin and TTC reagents were obtained from Sigma, USA. Assays to detect IL-6, IL-10, TNF-α, and iNOS were provided by Jiancheng Bio. Ins., China. Rabbit anti-Akt, anti-Phospho-Akt (p-Akt), anti-mTOR, anti-Phospho-mTOR (anti-p-mTOR), anti-P38, anti-Phospho-p38 (anti-p-P38), anti-LC3, anti-Beclin-1, antimicrotubule-associated protein (anti-MAP-2), anti-TLR4 and anti-IL-1 were obtained from Abcam, USA). Rabbit anti-GAPDH was purchased from Beijing Zhongshan Jinqiao Bio., China. Horseradish peroxidase linked goat anti-rabbit IgG was provided by Santa Cruz Biotechnology, US. Groups and Drug Administration 300 rats were divided to 7 groups: (1) sham (n = 60), rats had I/R procedures, without the insertion of nanofilament to CCA; (2) I/R (n = 60), the rats had cerebral ischemia by ligation for 2 hrs, and reperfusion for 1 day; (3) 25 mg/kg deltonin (n = 30), (4) 50 mg/kg deltonin (n = 30), and (5) 100 mg/kg deltonin (n = 60). Rats were injected intraperitoneally with 25, 50, 100 mg/kg deltonin at 2 hrs after ischemia; (6) 100 mg/kg deltonin + 10 μM LY294002 (n = 30), the rats were slowly injected intraventricularly with 10 μL 10 μM LY294002 at 20 mins prior to ischemia; (7) 100 mg/kg deltonin + 5 μM anisomycin (n = 30), the rats were slowly injected intraventricularly with 10 μL 5 μM anisomycin at 20 mins prior to ischemia. Deltonin was dissolved in ethanol and saline to reach an ethanol concentration of 5%. 12 LY294002 and anisomycin were dissolved in 5% ethanol. Rat in sham and I/R groups had same volume of 5% ethanol in normal saline. After 24 hrs reperfusion, rats were anesthetized and decapitated. Figure 1B shows the experiment protocols.
Animals

Assessments of Infarct Volumes, Neurological Deficits and Brain Water Contents
After reperfusion, the rats (n = 6) were anesthetized and decapitated. The brains were dissected and sliced (5 slices of 1.5-mm tissues). They were stained with 1% TTC for 30 min and fixed by 4% paraformaldehyde. We recorded the stained parts and calculated the volumes by ImageJ. Neurological deficits were evaluated: 0, rat had normal behavior; 1, rat cannot fully stretch left front leg; 2, rat turns around to a circle; 3, rat falls to the left; 4, rat cannot move, and lost consciousness. Brain water contents (n = 6) were detected at 24 hrs after reperfusion. We measured infarct brain hemispheres as wet weight, dried them overnight at 105 to get dry weight.
Brain water was calculated as [(wet weightdry weight)/wet weight]×100%.
Rotarod Test
Rotarod test system (TSE, Germany) evaluated neurological functions. 13 Rat was trained for 3 days prior to surgeries. The speed was accelerated from 4 to 40 rpm in 5 mins. Prior to or after I/R/R, each rat was detected for triplicates. We recorded the time needed for them to run on the rods.
ELISA
ELISA was utilized to measure the protein expressions of IL-6, IL-10, TNF-α, and iNOS. Firstly, we extracted the brain tissues from ischemic area, homogenized them (10%, w/v), and had centrifugation at 2,500 r/min for 10 mins. In the supernatants, the protein concentration was detected by ELISA. We visualized the results through the Multiskan MK3 (Thermo Scientific, USA).
Western Blotting
We isolated the hippocampus wand measured the protein concentration via BCA detection kit (Beyotime, China). The proteins were separated via 10 SDS-PAGE and electro-transferred to a nitrocellulose membrane. The membrane was blocked by 5% skim milk. After washing, it was treated with anti-Akt (1:500), anti-p-Akt (1:500), anti-mTOR (1:500), anti-mTOR (1:500), anti-P38 (1:600), anti-p-P38 (1:600), anti-LC3 (1:1000), anti-Beclin-1 (1:1000), anti-MAP-2 (1:1000), anti-TLR4 (1:1000) and anti-IL-1 (1:1000). All were purchased from Abcam, USA. Then, it was incubated with secondary antibody for 2 hrs. We visualized the signals via Odyssey system (LI-COR, USA) and analyzed by ImageJ.
Statistical Analysis
We showed the data as the means±standard deviation (S.D.). The comparisons were carried out by one-way ANOVA with Holm-Sidak post hoc test. Differences were regarded to be significant as P<0.05.
Results
Deltonin Improved Neurological Function and Reduced Cerebral Infarction
Compared with the sham, a great deficit was detected in I/R (P < 0.01), which were markedly relieved by deltonin (P<0.05, P<0.01) (Figure 2A and B). From Figure 2C and D, we observed that cerebral I/R greatly elevated infarct volumes and brain water contents (P<0.01); however, this effect was rescued by deltonin (P<0.05, P<0.01). Figure 2E shows the Western blot results. We found that MAP-2 in I/R was much lower compared with sham (P<0.01). Deltonin elevated concentrations of MAP-2 (P<0.05, P<0.01). It was obvious that deltonin improved neurological function and reduced cerebral infarction in the rats after I/R. Deltonin Reduced Autophagy Activities Through PI3K/Akt/mTOR Signaling In Figure 3A , it was demonstrated that LY294002 (inhibitor of PI3K/Akt) was markedly decreased in the neurological score, when comparing with deltonin group (P<0.05). Figure 3B shows the infarct volumes from the groups of sham, I/R, high-dose deltonin, and high-dose deltonin +LY294002. It was obvious that deltonin could reduce the infarct volumes. Figure 3C and D showed the Western blot.
No obvious difference was observed in expressions of Akt and mTOR (P > 0.05). Compared with sham, I/R decreased the expressions of p-Akt and p-mTOR, and increased the levels of LC3II and Beclin-1. Due to this reason, ratios of LC3-II/LC3-I and Beclin-1/GAPDH were increased (P < 0.01) ( Figure 3D ). However, deltonin had a great elevation in p-Akt and p-mTOR in contrast with I/R (P < 0.01) ( Figure 3D ). In addition, the LC3-II/LC3-I and Beclin-1/ GAPDH ratios reduced greatly by deltonin (P<0.01) ( Figure 3D ). However, LY294002 greatly decreased p-Akt and pmTOR expressions and elevated the ratios of LC3-II/ LC3-I and Beclin-1/GAPDH than the I/R + deltonin (P<0.05) ( Figure 3D ). The data indicated that deltonin attenuated autophagies and had neuroprotection to rats with I/R.
Deltonin Suppressed Inflammations
Through TLR4/P38/MAPK in I/R Rats From Figure 4 , the ultrastructural changes among sham, I/R, high-dose deltonin, and high-dose deltonin+LY294002 showed that deltonin reduced autophagy activities during cerebral I/R injury. Figure 5A demonstrated that anisomycin (activator of p38/MAPK) decreased the neurological scores than deltonin group (P<0.05). Figure 5B showed that deltonin reduced the infarct volume, but anisomycin attenuated the effect. Figure 5C showed the protein expressions of TLR4, p-38, p-p38, and IL-1. No significant difference was found in the expressions of p38 in all groups (P>0.05), but TLR4, p-p38, and IL-1 were elevated greatly in I/R (P<0.01). Reversely, TLR4, p-p38, and IL-1 reduced by deltonin (P<0.01) ( Figure 5C and D) . However, anisomycin up-regulated the expressions of TLR4, p-p38, and IL-1 (P<0.05). Figure 6 showed the ELISA results about inflammatory factors of IL-6 ( Figure 6A ), IL-10 ( Figure 6B ), TNF-α ( Figure 6C ), and iNOS (downstream to TLR4) ( Figure 6D) . It was noted that IL-6, TNF-α, and iNOS were elevated greatly after I/R (P < 0.01). But IL-10 was markedly inhibited than sham (P < 0.01). With 100 mg/kg deltonin, IL-6, TNF-α, and iNOS were greatly decreased, but IL-10 was markedly promoted than I/R rats (P<0.01). But LY294002 and anisomycin up-regulated the IL-6, TNF-α, and iNOS and downregulated IL-10 (P<0.01). It was identified that deltonin attenuated the inflammation impacts of I/R in rats.
Discussions
It was well established that neurological functions, infarct volumes and brain water contents are the major indicators for cerebral ischemia/reperfusion injuries. An effective treatment could usually pose an impact in the three factors. For example, Y. Lin reported the neuroprotection effects from resveratrol on I/R injuries in rat by TRPC6/CREB. 14 Resveratrol lowered the neurological disorders and decreased brain infarctions at 1 day after reperfusions Microtubule-Associated Protein-2 (MAP-2) is a neuronspecific phosphoprotein which is measured as a marker of ischemic injury following cerebral ischemia. 15 In this study, we found that MAP-2 in I/R was much lower compared with sham, and deltonin elevated concentrations of MAP-2. Our study results are in agreement with the results of the studies by previous researches which represented that MAP-2 decreased during cerebral I/R. 14, 16 In our experiments, we noticed a great deficit was detected in I/R, which were markedly relieved by deltonin, compared with the sham. We observed that cerebral I/R greatly elevated infarct volumes and brain water contents; however, this effect was rescued by deltonin. It was obvious that deltonin improved neurological function and reduced cerebral infarction in the rats after I/R. According to Sai Ma in 2015, autophagy activation during cardiac I/R could either antagonize cardiac pathogenesis or contribute to further myocardium damage. 17 In our experiments, I/R increased the levels of LC3II and Beclin-1, which were 2 autophagy indicators. I/R also decreased the expressions of p-Akt and p-mTOR. However, deltonin had a great elevation in p-Akt and p-mTOR in contrast with I/R, and in addition, reduced the expressions of LC3-II and Beclin-1 greatly. Moreover, LY294002, an indicator of PI3K/Akt, greatly elevated the ratios of LC3-II Beclin-1. The data indicated that deltonin reduced autophagy and had neuroprotection to rats with I/R through PI3K/Akt/ mTOR signaling.
TLR4/p38/MAPK signaling pathway was widely known to participate in the activation of inflammations. For instance, J. Li demonstrated that oridonin protected against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways. 18 In 2018, JP. Dai also reported that oxymatrine inhibited influenza a virus replication and inflammation via TLR4, p38 MAPK and NF-κB Pathways. 19 There were no significant differences found in the expressions of p38 in all groups, but TLR4, p-p38, and IL-1 were elevated greatly in I/R group. Reversely, TLR4, p-p38, and IL-1 reduced by deltonin. But anisomycin, that could activate p38/MAPK, up-regulated the expressions of TLR4, p-p38, and IL-1. In addition, we detected the protein expressions of inflammatory factors were elevated greatly by I/R, and IL-10 was markedly reduced. By 100 mg/kg deltonin, IL-6, TNF-α, and iNOS were greatly decreased, but IL-10 was markedly promoted than I/R rats. But LY294002 and anisomycin up-regulated the IL-6, TNF-α, and iNOS and down-regulated IL-10 in the I/R+LY294002+deltonin and I/R+anisomycin+deltonin groups than the I/R+deltonin group. Obviously, deltonin attenuated the inflammation impacts of I/R through TLR4/p38/ MAPK signaling pathway.
Conclusions
Deltonin could suppress ischemic brain injury by regulating autophagy and inflammation during I/R. Deltonin can be an efficient therapeutic method for patient with ischemia. 
